Miah Jung PharmD

Pharmacologist, Center for Drug Evaluation and Research, FDA

Miah Jung joined FDA’s Office of Scientific Investigations in 2012. Dr. Jung serves as a subject matter expert in Good Clinical Practice (GCP) inspections to evaluate data integrity, quality, and subject safety in clinical studies for FDA’s Bioresearch Monitoring (BIMO) Program.